These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 7935324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Heikkilä J, Jalava A, Eriksson K.
    Biochem Biophys Res Commun; 1993 Dec 30; 197(3):1185-93. PubMed ID: 8280132
    [Abstract] [Full Text] [Related]

  • 5. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
    Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F.
    J Biol Chem; 1991 Aug 25; 266(24):15771-81. PubMed ID: 1874734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles.
    Heinrich R, Kraiem Z.
    J Clin Endocrinol Metab; 1997 Jun 25; 82(6):1839-44. PubMed ID: 9177393
    [Abstract] [Full Text] [Related]

  • 9. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Schächtele C, Klemm K, Grunicke H.
    Br J Cancer; 1996 Sep 25; 74(6):897-905. PubMed ID: 8826855
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells.
    Fagerström S, Påhlman S, Gestblom C, Nånberg E.
    Cell Growth Differ; 1996 Jun 25; 7(6):775-85. PubMed ID: 8780891
    [Abstract] [Full Text] [Related]

  • 11. Association of protein kinase C activation with induction of ornithine decarboxylase in murine but not human keratinocyte cultures.
    Fischer SM, Lee ML, Maldve RE, Morris RJ, Trono D, Burow DL, Butler AP, Pavone A, Warren B.
    Mol Carcinog; 1993 Jun 25; 7(4):228-37. PubMed ID: 8352882
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of proline-rich protein tyrosine kinase 2 in differentiation-dependent signaling in human epidermal keratinocytes.
    Schindler EM, Baumgartner M, Gribben EM, Li L, Efimova T.
    J Invest Dermatol; 2007 May 25; 127(5):1094-106. PubMed ID: 17205062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signal-regulated kinase and ornithine decarboxylase.
    da Rocha AB, Mans DR, Lenz G, Fernandes AK, de Lima C, Monteiro VF, Gonçalves D, Moreira JC, Brunetto AL, Rodnight R, Schwartsmann G.
    Pathobiology; 2000 May 25; 68(3):113-23. PubMed ID: 11174068
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of fetal calf serum-stimulated proliferation of rabbit cultured tracheal smooth muscle cells by selective inhibitors of protein kinase C and protein tyrosine kinase.
    Hirst SJ, Webb BL, Giembycz MA, Barnes PJ, Twort CH.
    Am J Respir Cell Mol Biol; 1995 Feb 25; 12(2):149-61. PubMed ID: 7865214
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.